Literature DB >> 20351344

Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

John P Forman1, Jonathan S Williams, Naomi D L Fisher.   

Abstract

Vitamin D regulates the renin-angiotensin system (RAS) in experimental animals, but corresponding human data are limited. We examined the relation between plasma 25-hydroxyvitamin D and elements of the RAS in 184 normotensive individuals in high sodium balance; these included circulating levels of plasma renin activity and angiotensin II (Ang II) and the renal plasma flow response to infused Ang II, which is an indirect measure of the intrinsic RAS activity in the kidney. Compared with individuals with sufficient 25-hydroxyvitamin D levels (> or = 30.0 ng/mL), those with insufficiency (15.0 to 29.9 ng/mL) and deficiency (<15.0 ng/mL) had higher circulating Ang II levels (P for trend=0.03). Moreover, those with vitamin D deficiency had significantly blunted renal plasma flow responses to infused Ang II (mean decrease of 115 mL/min per 1.73 m(2) in renal plasma flow versus 145 mL/min per 1.73 m(2) among those with sufficient vitamin D levels; P for trend=0.009). Although plasma renin activity was higher among individuals with insufficient levels of vitamin D, the result was not statistically significant. These data suggest that low plasma 25-hydroxyvitamin D levels may result in upregulation of the RAS in otherwise healthy humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351344      PMCID: PMC3023301          DOI: 10.1161/HYPERTENSIONAHA.109.148619

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

Review 1.  Minireview: vitamin D receptor: new assignments for an already busy receptor.

Authors:  Anthony W Norman
Journal:  Endocrinology       Date:  2006-08-31       Impact factor: 4.736

2.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

Authors:  Gérard M London; Alain P Guérin; Francis H Verbeke; Bruno Pannier; Pierre Boutouyrie; Sylvain J Marchais; Fabien Mëtivier
Journal:  J Am Soc Nephrol       Date:  2007-01-03       Impact factor: 10.121

Review 3.  Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts.

Authors:  Evelyne van Etten; Chantal Mathieu
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07-19       Impact factor: 4.292

4.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.

Authors:  John P Forman; Edward Giovannucci; Michelle D Holmes; Heike A Bischoff-Ferrari; Shelley S Tworoger; Walter C Willett; Gary C Curhan
Journal:  Hypertension       Date:  2007-03-19       Impact factor: 10.190

5.  Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

Authors:  Jared P Reis; Denise von Mühlen; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

6.  Behavioural and physical characteristics associated with vitamin D status in women.

Authors:  Julie A Pasco; Margaret J Henry; Geoffrey C Nicholson; Sharon L Brennan; Mark A Kotowicz
Journal:  Bone       Date:  2009-03-02       Impact factor: 4.398

7.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Hypertension       Date:  2008-10-06       Impact factor: 10.190

8.  Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

Authors:  Masahide Mizobuchi; Jeremiah Morrissey; Jane L Finch; Daniel R Martin; Helen Liapis; Tadao Akizawa; Eduardo Slatopolsky
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

9.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey.

Authors:  Robert Scragg; MaryFran Sowers; Colin Bell
Journal:  Am J Hypertens       Date:  2007-07       Impact factor: 2.689

10.  1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway.

Authors:  Dilip K Deb; Yunzi Chen; Zhongyi Zhang; Yan Zhang; Frances L Szeto; Kari E Wong; Juan Kong; Yan Chun Li
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-04
View more
  119 in total

1.  Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative.

Authors:  Macarius M Donneyong; Carlton A Hornung; Kira C Taylor; Richard N Baumgartner; John A Myers; Charles B Eaton; Eiran Z Gorodeski; Liviu Klein; Lisa W Martin; James M Shikany; Yiqing Song; Wenjun Li; JoAnn E Manson
Journal:  Circ Heart Fail       Date:  2014-11-14       Impact factor: 8.790

Review 2.  Vitamin D: roles in renal and cardiovascular protection.

Authors:  Yan C Li
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 3.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.

Authors:  Anand Vaidya; Jonathan S Williams
Journal:  Metabolism       Date:  2011-11-09       Impact factor: 8.694

4.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

5.  Elite athletes as research model: vitamin D insufficiency associates with elevated central blood pressure in professional handball athletes.

Authors:  Pascal Bauer; Lutz Kraushaar; Sophie Hölscher; Shahin Tajmiri-Gondai; Oliver Dörr; Holger Nef; Christian Hamm; Astrid Most
Journal:  Eur J Appl Physiol       Date:  2019-08-19       Impact factor: 3.078

Review 6.  The renin-angiotensin-aldosterone system and calcium-regulatory hormones.

Authors:  A Vaidya; J M Brown; J S Williams
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

7.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

Review 8.  Seasonal variations in cardiovascular disease.

Authors:  Simon Stewart; Ashley K Keates; Adele Redfern; John J V McMurray
Journal:  Nat Rev Cardiol       Date:  2017-05-18       Impact factor: 32.419

9.  Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.

Authors:  Q Cheng; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2012-12-19       Impact factor: 10.122

10.  Effect of vitamin D supplementation on blood pressure in blacks.

Authors:  John P Forman; Jamil B Scott; Kimmie Ng; Bettina F Drake; Elizabeth Gonzalez Suarez; Douglas L Hayden; Gary G Bennett; Paulette D Chandler; Bruce W Hollis; Karen M Emmons; Edward L Giovannucci; Charles S Fuchs; Andrew T Chan
Journal:  Hypertension       Date:  2013-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.